Clinical Studies

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.

LNG-IUD and the risk of gynecologic and breast cancers, contraception and body weight, and preferred ways to get hormonal birth control.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.

Answers for health care providers about prescribing extended contraception supplies.

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

A patient-centered decision aid for tubal sterilization counseling, IUD self-removal experiences, and counseling about pain and medication abortion.

OTC birth control pill self-selection, adherence, and interest; IUD expulsion risks; and IUD and implant side effects.

Abortion information on TikTok, doxy-PEP effectiveness in cis-gendered women; new data on UPA-EC and implant insertion; and a survey of pain with IUD insertion.